×

ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy

  • US 9,617,319 B2
  • Filed: 04/16/2014
  • Issued: 04/11/2017
  • Est. Priority Date: 11/17/2009
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating a Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD) patient that has an elevated level of serum creatine kinase, the method comprising administering to the patient an amount of a polypeptide comprising an amino acid sequence that is at least 90% identical to the sequence of amino acids 29-109 of SEQ ID NO:

  • 2.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×